Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totaling 50,147 shares, an increase of 227.3% from the April 30th total of 15,320 shares. Based on an average trading volume of 55,256 shares, the days-to-cover ratio is currently 0.9 days.
Ono Pharmaceutical Trading Down 1.1%
Shares of OTCMKTS:OPHLY traded down $0.05 during trading on Friday, hitting $4.94. The stock had a trading volume of 28,498 shares, compared to its average volume of 26,316. Ono Pharmaceutical has a 12-month low of $3.35 and a 12-month high of $5.75. The stock has a 50-day simple moving average of $5.08 and a two-hundred day simple moving average of $4.92.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.
Read More
- Five stocks we like better than Ono Pharmaceutical
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
- MarketBeat Week in Review – 05/25 – 05/29
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
